FILTER

FILTERED INTERVIEW RESULTS

Fabio Fiscaletti

CEO, MASTELLI
Mastelli is a small Italian pharma company with bold plans for expansion.

Michele Diaferia

CEO, ITEL GROUP
Itel Group describes the on-going development of its proton linear accelerator.

Nanding Zhao

CEO, NERVIANO MEDICAL SCIENCES (NMS) GROUP
NMS is one of the largest kinase inhibitors-focused oncology drug discovery companies in Italy.

Giovanni Mariani

CEO, LISAPHARMA
Lisapharma describes the challenges Italian pharma producers have experienced over the past two years.

Rocco Pavese

CEO, GENETIC SPA
Genetic is an Italian CDMO founded in 2007 dedicated to the research and development, manufacturing, licensing-out and marketing of medicines.

Alessia Valducci

CEO, VALPHARMA
Valpharma is an Italian CMO involved in pharmaceutical development and contract manufacturing specializing in solid oral dosage medicines and nutraceuticals, both developed with modified-release technologies.

Pasquale de Blasio

FOUNDER, INTEGRATED SYSTEMS ENGINEERING (ISE)
Integrated Systems Engineering sets out its objectives to develop its TMA technology and move it into diagnostics and to build a biobank of organoids.

Massimo Versace

COUNTRY MANAGER, SUN PHARMA ITALY
Sun Pharma discusses its’ operations in Italy.

Giorgio Palu

PRESIDENT, AIFA
The Italian Medical Agency (AIFA) explains the current issues facing Italy’s life science industry.

Pierfrancesco Morosini

CEO, ICROM
Icrom is an Italian CDMO leader for the production of APIs and GMP intermediates.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Africa Energy 2025

GBR is pleased to release its Africa Energy 2025 report, following four months of interviews and research across Sub-Saharan Africa, during which time we met with over 120 companies, including those in the upstream, midstream, and downstream sectors, as well as governments, financiers, and service providers.

PARTNER EVENTS